Harvard Bioscience INC: 1 tracked 2026 layoff event(s), 0 workers counted, highest AI score 3.
AI score 3 (80% interval 3–4) · evidence grade D · US · Instruments / Medical Devices
Stated reason: On January 23, 2026, the Board of Directors of Harvard Bioscience, Inc. (the “Company”) approved management’s comprehensive plan, referred to as Project Viking, for the strategic consolidation of its manufacturing operations to improve efficiency and support long-term growth. The Company will close its manufacturing facility in Holliston, MA and transition U.S. production to its manufacturing hub in Minneapolis, MN. …
Why 3: Plant, store or site closure · Drivers: contrary evidence −0.6, industry AI exposure +0.5, role AI exposure +0.1
Signals: attribution 0.0, primary 0.0, exec 0.0, role exposure 0.474, industry exposure 0.712, AI investment 0.0, contrary 0.4 · named roles: Computer and Information Systems Managers, General and Operations Managers, Machinists, Production Workers, All Other
Headcount basis: not disclosed
Company AI financials (AI spending, revenue, earnings-call AI mentions) are coming soon to this page.
